Issue 52, 2013

Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor

Abstract

Hsp90, a key target in cancer therapy, has been identified as the main partner of oleocanthal, an olive oil bioactive compound. A combination of chemical and biological assays disclosed its mechanism of action at the molecular level.

Graphical abstract: Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor

Supplementary files

Article information

Article type
Communication
Submitted
12 Mar 2013
Accepted
09 May 2013
First published
09 May 2013

Chem. Commun., 2013,49, 5844-5846

Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor

L. Margarucci, M. C. Monti, C. Cassiano, M. Mozzicafreddo, M. Angeletti, R. Riccio, A. Tosco and A. Casapullo, Chem. Commun., 2013, 49, 5844 DOI: 10.1039/C3CC41858H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements